SearcharxivSearch

arXiv subjects

Baoshun Wang

Publications and source records attributed to Baoshun Wang.

2 recordsLinked to original sources

Semi-Supervised Virtual Staining via Morphology Preservation and Histopathological Realism Constraints

Virtual staining aims to computationally generate target-stained histopathological images while reducing the cost and time associated with conventional staining procedures. However, existing methods rely predominantly on strictly paired and accurately registered training data, which are difficult and expensive to obtain in routine practice. To reduce this dependence, we propose a stable semi-supervised virtual staining framework that jointly exploits both limited paired data and abundant unpaired source images. Directly incorporating unpaired images is challenging because their generated results lack corresponding targets for supervision, potentially leading to unrealistic staining, morphological degradation, or even training collapse. To obtain reliable supervision from these images, Hessian-derived morphology preservation extracts structural cues from each source image and constrains the generated output to retain tissue morphology. Histopathological realism constraints further guide the output toward plausible target-stain characteristics, preventing the source-derived structural supervision from degenerating into contour enhancement or simple color transformation. Together, the two components suppress structural and appearance drift, stabilize semi-supervised stain translation, and promote the preservation of diagnostically relevant information. Extensive experiments on H&E-to-IHC translation for Ki67 and HER2, as well as FFPE-to-H&E translation, demonstrate consistent improvements in image quality, morphology preservation, robustness, and downstream diagnostic performance. Code will be available.

cs.CV

Beyond Diagnostic Performance: Revealing and Quantifying Ethical Risks in Pathology Foundation Models

Pathology foundation models (PFMs), as large-scale pre-trained models tailored for computational pathology, have significantly advanced a wide range of applications. Their ability to leverage prior knowledge from massive datasets has streamlined the development of intelligent pathology models. However, we identify several critical and interrelated ethical risks that remain underexplored, yet must be addressed to enable the safe translation of PFMs from lab to clinic. These include the potential leakage of patient-sensitive attributes, disparities in model performance across demographic and institutional subgroups, and the reliance on diagnosis-irrelevant features that undermine clinical reliability. In this study, we pioneer the quantitative analysis for ethical risks in PFMs, including privacy leakage, clinical reliability, and group fairness. Specifically, we propose an evaluation framework that systematically measures key dimensions of ethical concern: the degree to which patient-sensitive attributes can be inferred from model representations, the extent of performance disparities across demographic and institutional subgroups, and the influence of diagnostically irrelevant features on model decisions. We further investigate the underlying causes of these ethical risks in PFMs and empirically validate our findings. Then we offer insights into potential directions for mitigating such risks, aiming to inform the development of more ethically robust PFMs. This work provides the first quantitative and systematic evaluation of ethical risks in PFMs. Our findings highlight the urgent need for ethical safeguards in PFMs and offer actionable insights for building more trustworthy and clinically robust PFMs. To facilitate future research and deployment, we will release the assessment framework as an online toolkit to support the development, auditing, and deployment of ethically robust PFMs.

cs.CV